£49k
+103%vs Dec 2024Active14412749Private limited companyLondon
TRES ALCHEMIX LTD
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Tres Alchemix Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Tres Alchemix Ltd sell?
Registered activity: Manufacture of basic pharmaceutical products (SIC 21100). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
TRES ALCHEMIX LTD is an active private limited company (company number 14412749) incorporated on 11 October 2022, registered in London. Its registered activity is manufacture of basic pharmaceutical products (SIC 21100). Latest micro accounts cover the period ending 31 December 2025, showing net assets of £49k, with 4 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 103% on the prior period (£24k).
Peer position · net assets
By net assets it sits in the top quarter of 143 comparable companies in London (median £100, upper quartile £10k).
02
Ownership and control
No active person with significant control is registered.
- Dr. Takuma Morimoto
- owns 25–50% of shares
- holds 25–50% of voting rights
- Dr. Hisashi Hashimoto
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 11 October 20224 yrs ago
- Next accounts due
- 30 September 2027in 338 days
- Confirmation statement due
- 25 October 2027in 363 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 21100
- Manufacture of basic pharmaceutical products
- SIC 72190
- Other research and experimental development on natural sciences and engineering
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
4
+33%vs Dec 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | £49k | — | — | £428k | — | — | 4 |
| 31 December 2024 | £24k | — | — | £39k | — | — | 3 |
Current ratio0.85Current assets ÷ creditors within one year
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets above zeroNet assets £49,090 at 31 December 2025
- Net assets up 10% or more on the prior period+102.6% vs prior period
- Current assets below creditors within one yearCurrent ratio 0.85
- Incorporated two to five years agoIncorporated 11 October 2022
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 363 days
- Next accounts duein 338 days
- Accounts period endNet assets £49k · micro accounts
- Accounts period endNet assets £24k · micro accounts
- Incorporated
08
Similar companies in London
09
Reminders for TRES ALCHEMIX LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.